用生物技术方法制备的家禽凝的特性,以在分子水平上进行有针对性的变化
Aneta Prokopová1, Pavel Mokrejš1, Robert Gál2
1Department of Polymer Engineering, Faculty of Technology, Tomas Bata University in Zlín, 760 01 Zlín, Czech Republic.
International journal of molecular sciences
|January 23, 2024
概括
肉凝为高级应用提供了一个有前途的来源. 这项研究证实了其抗氧化特性,适当的分子量分布和微生物安全性,使其成为传统动物衍生原蛋白的可行替代品.
科学领域:
- 生物技术和生物材料科学 生物技术和生物材料科学
- 食品科学与技术 食品科学与技术
- 生物化学 生物化学
背景情况:
- 肉原蛋白是一种有价值的,未充分利用的来源,用于生产凝和水解剂.
- 用酶进行生物技术加工,可以在分子层面上定制凝的特性.
- 有针对性的凝性质对于先进的化品,制药,医疗和食品应用至关重要.
研究的目的:
- 为了描述肉凝的抗氧化活性,分子重量分布和功能组.
- 评估肉凝在各种应用中的微生物安全性.
- 评估肉凝作为传统原蛋白来源的可持续替代品.
主要方法:
- 使用DPPH (2,2-二-1-皮克里利水) 和ABTS (2,2-阿齐诺比斯-3-乙烯扎林-6-硫酸) 试验评估的抗氧化活性.
- 用凝透色谱与折射计检测 (GPC-RID) 确定的分子重量分布.
- 福里埃变换红外光谱学 (FTIR) 分析了功能组和多链配置.
- 使用MALDI (矩阵辅助激光脱离离电离) 评估的微生物群体包括Sabouraud乳糖 (SDA),盘子计数 (PCA),三性大豆 (TSA) 和紫色红胆汁乳糖 (VRBL).
主要成果:
- 肉凝表现出显著的抗氧化活性,超过ABTS基的80%和DPPH基的69%.
- 在GPC-RID分析中,所有凝样本中都发现了典型的α,β和γ链.
- FTIR光谱学证实了特征性的原分裂产品振动区域的存在 (胺基A,B,I,II,III).
- 微生物学分析表明没有不良的细菌污染,确保适合先进的应用.
结论:
- 肉凝具有显著的抗氧化能力和理想的分子特性.
- 该材料在微生物学上是安全的,支持其在苛刻的应用中使用.
- 肉凝是一种可行的,有前途的替代品,可以替代来自陆地动物来源的凝.
相关概念视频
Recombinant DNA
Overview
Transgenic Organisms
Overview
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...


